Interventional cardiology, cath lab technology, TCT, transcatheter cardiovascular therapeutics

The volume of information attendees receive at the annual Transcatheter Cardiovascular Therapeutics (TCT) interventional cardiology conference can be overwhelming. So, to prepare for the meeting, here is a list of some key items that will be covered in sessions, live cases and late-breaking trial presentations. It includes videos, articles, news and U.S. Food and Drug Administration (FDA) clearances that will be among the hottest topics at this year’s TCT, in Washington, D.C., Oct. 30 - Nov. 2. 

October 27, 2016 — BioTrace Medical Inc. said it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Tempo Lead, an temporary pacing lead designed for use in procedures in which temporary pacing is indicated, including transcatheter aortic valve replacement (TAVR) and electrophysiology (EP) procedures.

Philips recently announced its latest image guidance solutions to be featured at the 2016 Transcatheter Cardiovascular Therapeutics meeting (TCT) in Washington, D.C., Oct. 29 – Nov. 2, 2016. Highlights will include the introduction of instant wave-Free Ratio (iFR) co-registration, which integrates iFR pullback data with the angiogram, and the third generation of HeartNavigator, live image guidance software for advanced structural heart disease procedures.

October 26, 2016 — The U.S. Food and Drug Administration (FDA) provided an update and additional information regarding patient safety issues involving the SynCardia Systems Temporary Total Artificial Heart (TAH-t) Companion 2 Driver System (C2 Driver System). The FDA also updated providers on recent events with an additional SynCardia pneumatic driver system, the Freedom Driver System. 

Medtronic announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the CoreValve Evolut R 34 mm valve, now the largest sized transcatheter aortic valve replacement (TAVR) system available in the United States.

Stereotaxis Inc. and Robert Wood Johnson University Hospital (RWJUH) announced that Zyad Younan, M.D., has completed more than 500 cardiac ablation procedures using the Niobe remote magnetic navigation system. Younan currently leads the Northeast region in catheter ablations performed using the Niobe system in the six-and-a-half years since installation.

A recent study from University of Alabama at Birmingham (UAB) researchers published in PLOS ONE compares different available treatments for stroke prevention in patients with non-valvular atrial fibrillation (NVAF).

Cardiovascular Disease Prevention Symposium: From Prevention to Intervention

The Human Animal Bond Research Initiative (HABRI) announced it has awarded a $44,000 grant to Duke University School of Medicine’s Division of Pediatric Cardiology for a new research study on the impact of therapy dogs on pediatric echocardiograms.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now